CFDE Data Portal | Search ANKRD49P2

	Label	Description
	ANKRD49P2 Gene (Entity type)	ENSG00000225349 - ANKRD49 pseudogene 2
	GSE111247 temozolomide LN-308 0 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE155031 catechin SH-SY5Y 5 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE128885 deferiprone macrophage 0 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE146612 amiodarone 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE150244 TRIM8 knockout 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE155031 catechin SH-SY5Y 6 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE128885 deferiprone macrophage 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE155031 catechin SH-SY5Y 6 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE233679 nicotinamide 6 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS

ANKRD49P2

ENSG00000225349 - ANKRD49 pseudogene 2

GSE111247 temozolomide LN-308 0 v 6 human up

A Gene Set from LINCS

GSE155031 catechin SH-SY5Y 5 v 3 human up

A Gene Set from LINCS

GSE128885 deferiprone macrophage 0 v 2 human up

A Gene Set from LINCS

GSE146612 amiodarone 2 v 3 human up

A Gene Set from LINCS

GSE150244 TRIM8 knockout 2 v 0 human up

A Gene Set from LINCS

GSE155031 catechin SH-SY5Y 6 v 0 human up

A Gene Set from LINCS

GSE128885 deferiprone macrophage 0 v 1 human up

A Gene Set from LINCS

GSE155031 catechin SH-SY5Y 6 v 3 human up

A Gene Set from LINCS

GSE233679 nicotinamide 6 v 3 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.